Cargando…
How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study
OBJECTIVES: Self-stigma is associated with lower patient activation levels for self-care in persons with type 2 diabetes mellitus (T2DM). However, the causal pathway linking self-stigma with patient activation for self-care has not been shown. In order to determine how self-stigma affects patient ac...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239528/ https://www.ncbi.nlm.nih.gov/pubmed/32423931 http://dx.doi.org/10.1136/bmjopen-2019-034757 |
_version_ | 1783536708729438208 |
---|---|
author | Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki |
author_facet | Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki |
author_sort | Kato, Asuka |
collection | PubMed |
description | OBJECTIVES: Self-stigma is associated with lower patient activation levels for self-care in persons with type 2 diabetes mellitus (T2DM). However, the causal pathway linking self-stigma with patient activation for self-care has not been shown. In order to determine how self-stigma affects patient activation for self-care, we tested a two-path hypothetical model both directly and as mediated by self-esteem and self-efficacy. DESIGN: A cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Japan. PARTICIPANTS: T2DM outpatients receiving treatment (n=209) completed a self-administered questionnaire comprising the Self-Stigma Scale, Patient Activation Measure, Rosenberg Self-Esteem Scale, General Self-Efficacy Scale, Patient Health Questionnaire, haemoglobin A1c test, age, sex and body mass index. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma levels were measured by using the Self-Stigma Scale. Patient activation levels were measured by the Patient Activation Measure. RESULTS: Path analysis showed a strong relationship between self-stigma and patient activation (χ(2)=27.55, p=0.120; goodness-of-fit index=0.97; adjusted goodness-of-fit index=0.94; comparative fit index=0.98; root mean square error of approximation=0.04). Self-stigma had a direct effect on patient activation (β=−0.20; p=0.002). Indirectly, self-stigma affected patient activation along two paths (β=0.31; p<0.001) by reducing self-esteem (β=−0.22; p<0.001) and self-efficacy (β=−0.36; p<0.001). CONCLUSIONS: Due to the cross-sectional design of the study, longitudinal changes between all the variables cannot be established. However, the findings indicate that self-stigma affected patient activation for self-care, both directly and as mediated by self-esteem and self-efficacy. Interventions that increase self-esteem and self-efficacy may decrease self-stigma in patients with T2DM, thus increasing patient activation for self-care. |
format | Online Article Text |
id | pubmed-7239528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-72395282020-05-28 How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki BMJ Open Diabetes and Endocrinology OBJECTIVES: Self-stigma is associated with lower patient activation levels for self-care in persons with type 2 diabetes mellitus (T2DM). However, the causal pathway linking self-stigma with patient activation for self-care has not been shown. In order to determine how self-stigma affects patient activation for self-care, we tested a two-path hypothetical model both directly and as mediated by self-esteem and self-efficacy. DESIGN: A cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Japan. PARTICIPANTS: T2DM outpatients receiving treatment (n=209) completed a self-administered questionnaire comprising the Self-Stigma Scale, Patient Activation Measure, Rosenberg Self-Esteem Scale, General Self-Efficacy Scale, Patient Health Questionnaire, haemoglobin A1c test, age, sex and body mass index. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma levels were measured by using the Self-Stigma Scale. Patient activation levels were measured by the Patient Activation Measure. RESULTS: Path analysis showed a strong relationship between self-stigma and patient activation (χ(2)=27.55, p=0.120; goodness-of-fit index=0.97; adjusted goodness-of-fit index=0.94; comparative fit index=0.98; root mean square error of approximation=0.04). Self-stigma had a direct effect on patient activation (β=−0.20; p=0.002). Indirectly, self-stigma affected patient activation along two paths (β=0.31; p<0.001) by reducing self-esteem (β=−0.22; p<0.001) and self-efficacy (β=−0.36; p<0.001). CONCLUSIONS: Due to the cross-sectional design of the study, longitudinal changes between all the variables cannot be established. However, the findings indicate that self-stigma affected patient activation for self-care, both directly and as mediated by self-esteem and self-efficacy. Interventions that increase self-esteem and self-efficacy may decrease self-stigma in patients with T2DM, thus increasing patient activation for self-care. BMJ Publishing Group 2020-05-17 /pmc/articles/PMC7239528/ /pubmed/32423931 http://dx.doi.org/10.1136/bmjopen-2019-034757 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Diabetes and Endocrinology Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study |
title | How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study |
title_full | How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study |
title_fullStr | How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study |
title_full_unstemmed | How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study |
title_short | How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study |
title_sort | how self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239528/ https://www.ncbi.nlm.nih.gov/pubmed/32423931 http://dx.doi.org/10.1136/bmjopen-2019-034757 |
work_keys_str_mv | AT katoasuka howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT fujimakiyuko howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT fujimorishin howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT isogawaakihiro howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT onishiyukiko howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT suzukiryo howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT uekikohjiro howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT yamauchitoshimasa howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT kadowakitakashi howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy AT hashimotohideki howselfstigmaaffectspatientactivationinpersonswithtype2diabetesacrosssectionalstudy |